Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.
about
Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergencies.Opioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption.Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project.Flumazenil, naloxone and the 'coma cocktail'.Use and Misuse of Opioids in Maine: Results From Pharmacists, the Prescription Monitoring, and the Diversion Alert Programs.Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system.Naloxone prolongs cutaneous nociceptive block by lidocaine in rats.A New Tool to Tackle the Opioid Epidemic: Description, Utility, and Results from the Maine Diversion Alert Program.Assessing the impact of prescribing directives on opioid prescribing practices among Veterans Health Administration providers.Validation of a Screening Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in a US Commercial Health Plan Claims Database.Cardiac Arrest Following Drug Abuse with Intravenous Tapentadol: Case Report and Literature Review.Negative outcomes of unbalanced opioid policy supported by clinicians, politicians, and the media.Characterization and Management of Patients with Heroin versus Nonheroin Opioid Overdoses: Experience at an Academic Medical Center.Co-prescribing naloxone does not increase liability risk.Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review.In Response to: "The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty".Beyond rescue: Implementation and evaluation of revised naloxone training for law enforcement officers.Is naloxone the best antidote to reverse tramadol-induced neuro-respiratory toxicity in overdose? An experimental investigation in the rat.Ethical pain management in the emergency department: the canary in the coal mine.Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB-13, in mice.[Diagnosis, differential diagnosis and therapy of substance use disorders in general hospital (general section)].Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy.The case for implementing the levels of prevention model: Opiate abuse on American college campuses.Mechanisms and the clinical relevance of complex drug-drug interactionsOld opioids, new concerns: the case of acetylfentanyl
P2860
Q28468357-932E64BF-E13D-4B1E-B89C-0317C67361D8Q33747985-EA363A3D-7605-4F31-A7D0-1A12098CDA57Q34481137-F2C25BE6-99B2-450C-8E19-900D59DFD803Q34498099-8CE15CC3-71BD-4614-917F-6A58E11DEF99Q37180212-C6063BC5-A515-4317-A76C-991D06ADC783Q37275831-F9204232-4365-4398-90AD-B6B8DFB0ECA1Q38693513-941B46AA-7ADB-4C23-917C-B86289EC0E9DQ38764593-CBE8C5AA-F590-44BF-B33D-18ED239B914AQ38830845-4EB6013B-8688-4171-94E5-98816E2BDE5FQ38878642-9CE26481-3B12-49D3-8249-F765F7849E8CQ39449028-6B5AC623-4059-49F4-A655-9747C7433897Q39987535-2013525C-B8C1-4256-A0B0-0F01456B68F3Q40366968-6E7B4E23-0928-4D3E-84D3-A7B930910677Q41657762-EEFD8F50-B73E-4094-B16E-42334BE73F16Q42687927-F3A5ABFE-3D92-4A9B-83C5-CCC459142CE3Q44340962-761652B4-0990-4EC0-9D33-18D95F23915EQ47604905-4A2BE617-1B41-4208-8E9C-B0BC90AF2B69Q47705786-535F4941-C5D2-48E0-9308-97CAD38BDD3FQ48035176-599EAA52-D854-4EE1-99C0-E678DD5A1A6EQ48251990-0BE22A8A-0CE1-4271-B873-938F08E31E2FQ48256064-67A014EC-3FFE-4479-A33E-15D02A16E49EQ49587859-0B7EA8E8-B1B5-450F-8A05-2B88AE509629Q53216213-CDA6A929-9FF4-41F0-95F7-E1DC66DF4C31Q57490721-D191D279-CAF9-4771-B91C-F1493F11B22EQ59218484-29728858-9E1A-44FE-8788-F04E8904174C
P2860
Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Review of naloxone safety for ...... gy and expanded public access.
@ast
Review of naloxone safety for ...... gy and expanded public access.
@en
type
label
Review of naloxone safety for ...... gy and expanded public access.
@ast
Review of naloxone safety for ...... gy and expanded public access.
@en
prefLabel
Review of naloxone safety for ...... gy and expanded public access.
@ast
Review of naloxone safety for ...... gy and expanded public access.
@en
P2860
P356
P1476
Review of naloxone safety for ...... gy and expanded public access.
@en
P2093
Daniel P Wermeling
P2860
P356
10.1177/2042098614564776
P577
2015-02-01T00:00:00Z